about
Viruses as co-factors for the initiation or exacerbation of lung fibrosisViruses in Idiopathic Pulmonary Fibrosis. Etiology and ExacerbationBench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentationInfection in severe asthma exacerbations and critical asthma syndrome.Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.Respiratory viruses from hospitalized children with severe pneumonia in the Philippines.Influenza entry pathways in polarized MDCK cells.Sidestream smoke exposure increases the susceptibility of airway epithelia to adenoviral infectionThe airway epithelium: soldier in the fight against respiratory virusesProvince-wide adenovirus type 3 outbreak with severe cases in New Brunswick.Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune responseIn vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodideSerotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regionsSubversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3.iTRAQ-Based and Label-Free Proteomics Approaches for Studies of Human Adenovirus InfectionsLoss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation.Determinants of initiation and progression of idiopathic pulmonary fibrosis.Changes in the number of CD31-CD45-Sca-1+ cells and Shh signaling pathway involvement in the lungs of mice with emphysema and relevant effects of acute adenovirus infection.Viral infection and aging as cofactors for the development of pulmonary fibrosis.Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer.Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum.Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoter.Association between respiratory viruses and exacerbation of COPD: a case-control study.Prevalence and quantitation of adenovirus DNA from human tonsil and adenoid tissues.In vitro antiviral activity of resveratrol against respiratory viruses.Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells.Stimulation of Dectin-1 and Dectin-2 during Parenteral Immunization, but Not Mincle, Induces Secretory IgA in Intestinal Mucosa.
P2860
Q27487313-A78893B1-92B2-4178-81C3-88CFEBE1289EQ28081676-957473AF-962F-4A5A-82E2-DBD122A0548FQ28386164-BEA41B95-24A2-4134-9F2D-75CA7A159B14Q30364236-EEBC06B8-7901-4554-98CF-52601E0D17B4Q30525107-45D95D00-32A2-455C-B68A-058C6D9A7C0CQ30529666-C9856D6F-926C-4DFB-89E3-05296D2DBD8EQ33934295-342BA53D-7ECC-4CE9-8D94-6BF5F03DEB99Q34482900-FEE18CCE-B6E9-4B40-8741-D5ABB38CB9ACQ34491598-6134A200-FA3F-4FDB-B862-1C325B0A269EQ34789802-38B1B2D3-83C4-49BB-AC1C-5234B1CF7AB6Q34998846-3FE5F598-CAB3-4972-8FFF-EBB14E246898Q35175103-9FBE65D6-042C-4067-BE67-18FD9DD282DDQ35193352-362A874C-360E-4433-8A0C-2F5023C6F393Q35528052-F2009CED-312A-4241-BD5E-BAC2F6E200B6Q36171914-ABD3A356-C772-463F-9ECE-3260ABC5594FQ36570681-2BADD43C-35F6-49FC-BBAC-CCEDFFC7ECA0Q36716644-FF358F57-4C94-497E-8868-9A4E84EB9E7CQ37033867-FA73E4E8-EDAB-4C67-B0A6-53528E52D2C5Q37116929-6ABA3E5C-D23F-4997-B04E-028A8F3E7137Q37371297-39E02D7A-8C77-4721-AF04-8DE28DE3E2CDQ37594222-3DFBF067-9A7F-478D-B906-648677714B40Q37712274-53B65DA0-E2D5-4854-B313-4EFC9666571AQ37815487-4EDD87D9-286D-4540-BC5E-A339508FF700Q38296825-C634E83B-1780-4981-8BBB-B9BCFED27090Q38721817-1251CB60-50EE-4886-93F5-7EF7007A18ABQ39900973-B74413AA-A483-42DD-9FCE-90AB45BC0B4AQ40164082-4483F76C-5516-4160-B104-746F0A4091C0Q42283872-E6C9EDEB-CF7F-462F-97F0-8350475E768BQ46497494-7D4828A6-6D88-46A5-838A-B0CAEE06A51EQ50064805-6B6502B4-3675-41C3-8FB6-FE3C1A69B6ADQ55261723-DD514CE9-7809-4D3A-9DD7-6DE96D731B27
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adenovirus infections and lung disease.
@en
type
label
Adenovirus infections and lung disease.
@en
prefLabel
Adenovirus infections and lung disease.
@en
P1476
Adenovirus infections and lung disease.
@en
P2093
James C Hogg
Shizu Hayashi
P304
P356
10.1016/J.COPH.2006.11.014
P577
2007-04-18T00:00:00Z